XML 85 R70.htm IDEA: XBRL DOCUMENT v3.19.1
Healthcare Technology Net Asset Exchange (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Mar. 15, 2019
Schedule of Equity Method Investments [Line Items]                        
Pre-tax gain on sale of business                 $ 0 $ 109,000,000 $ 0  
Loss from equity method investment in Change Healthcare         $ (23,000,000) $ 90,000,000 $ 61,000,000 $ 120,000,000        
Carrying value of equity method investments $ 3,513,000,000       3,728,000,000       3,513,000,000 3,728,000,000    
Tax Receivable Agreement (“TRA”) | Change Healthcare                        
Schedule of Equity Method Investments [Line Items]                        
Noncurrent liability         90,000,000         90,000,000    
Other | Tax Receivable Agreement (“TRA”) | Change Healthcare                        
Schedule of Equity Method Investments [Line Items]                        
Noncurrent liability 0               0      
Pre-tax credit representing reduction in TRA liability                 90,000,000      
After-tax credit representing reduction in TRA liability                 66,000,000      
Other | Operating Segments                        
Schedule of Equity Method Investments [Line Items]                        
Pre-tax credit representing reduction in TRA liability                   46,000,000    
Core MTS Businesses | Technology Solutions | Operating Segments                        
Schedule of Equity Method Investments [Line Items]                        
Gain from sale of business, after tax                     3,000,000,000  
Corporate Joint Venture                        
Schedule of Equity Method Investments [Line Items]                        
Carrying value of equity method investments 3,513,000,000       3,728,000,000       3,513,000,000 3,728,000,000    
Excess of carrying value over proportionate share of investment net assets 4,158,000,000       $ 4,472,000,000       4,158,000,000 4,472,000,000    
Corporate Joint Venture | Transition Services Agreements (“TSA”)                        
Schedule of Equity Method Investments [Line Items]                        
Total fees charged under the TSA                 60,000,000 91,000,000    
Corporate Joint Venture | Core MTS Businesses                        
Schedule of Equity Method Investments [Line Items]                        
Ownership interest in Joint Venture (percent)           70.00%            
Change Healthcare                        
Schedule of Equity Method Investments [Line Items]                        
Loss from equity method investment in Change Healthcare $ 32,000,000 $ 50,000,000 $ 56,000,000 $ 56,000,000         194,000,000 248,000,000 0  
Change Healthcare | Core MTS Businesses | Other | Operating Segments                        
Schedule of Equity Method Investments [Line Items]                        
Pre-tax gain on sale of business                     $ 3,900,000,000  
Change Healthcare | Core MTS Businesses | Technology Solutions | Operating Segments                        
Schedule of Equity Method Investments [Line Items]                        
Pre-tax gain on sale of business                   37,000,000    
Gain from sale of business, after tax                   22,000,000    
Proceeds from Divestiture of Businesses                   126,000,000    
Change Healthcare | Corporate Joint Venture                        
Schedule of Equity Method Investments [Line Items]                        
Ownership interest in Joint Venture (percent)                     70.00%  
Loss from equity method investment in Change Healthcare                 194,000,000 $ 248,000,000    
Provisional tax benefit                 76,000,000      
Pre-tax credit representing reduction in TRA liability     $ (90,000,000)           $ 90,000,000      
Change Healthcare, Inc. | Corporate Joint Venture                        
Schedule of Equity Method Investments [Line Items]                        
Ownership interest in Joint Venture (percent)                       30.00%